key: cord-0324869-tdtyybnc
authors: Choi, Jung-Hyun; Zhang, Xu; Zhang, Christine; Dai, David L.; Luo, Jun; Ladak, Reese; Li, Qian; Wiebe, Shane; Liu, Alex C.H.; Ran, Xiaozhuo; Yang, Jiaqi; Naeli, Parisa; Garzia, Aitor; Zhou, Lele; Mahmood, Niaz; Deng, Qiyun; Elaish, Mohamed; Lin, Rongtuan; Hobman, Tom; Pelletier, Jerry; Alain, Tommy; Vidal, Silvia; Duchaine, Thomas; Mazhab-Jafari, Mohammad T.; Mao, Xiaojuan; Jafarnejad, Seyed Mehdi; Sonenberg, Nahum
title: SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation
date: 2022-01-20
journal: bioRxiv
DOI: 10.1101/2022.01.19.476693
sha: 43cf5f7615c334a95dcd24e35533fed49b133c56
doc_id: 324869
cord_uid: tdtyybnc

Viruses evade the innate immune response by suppressing the production or activity of cytokines such as type I interferons (IFNs). Here we report the discovery of a novel mechanism by which the SARS-CoV-2 virus co-opts an intrinsic cellular machinery to suppress the production of the key immunostimulatory cytokine IFN-β. We reveal that the SARS-CoV-2 encoded Non-Structural Protein 2 (NSP2) directly interacts with the cellular GIGYF2 protein. This interaction enhances the binding of GIGYF2 to the mRNA cap-binding protein 4EHP, thereby repressing the translation of the Ifnb1 mRNA. Depletion of GIGYF2 or 4EHP significantly enhances IFN-β production, leading to reduced viral infection. Our findings reveal a new target for rescuing the antiviral innate immune response to SARS-CoV-2 and other RNA viruses.

Viruses evade the innate immune response by suppressing the production or activity of cytokines such as type I interferons (IFNs). Here we report the discovery of a novel mechanism by which the SARS-CoV-2 virus co-opts an intrinsic cellular machinery to suppress the production of the key immunostimulatory cytokine IFN-β. We reveal that the SARS-CoV-2 encoded Non-Structural Protein 2 (NSP2) directly interacts with the cellular GIGYF2

protein. This interaction enhances the binding of GIGYF2 to the mRNA capbinding protein 4EHP, thereby repressing the translation of the Ifnb1 mRNA.

Depletion of GIGYF2 or 4EHP significantly enhances IFN-β production, leading to reduced viral infection. Our findings reveal a new target for rescuing the antiviral innate immune response to SARS-CoV-2 and other RNA viruses.

Production of type I interferons (IFN-α and IFN-β) is pivotal to antiviral immunity as a host defence mechanism 1 . Replication of SARS-CoV-2 is sensitive to type I IFN expression in vitro [2] [3] [4] , and the life-threatening SARS-CoV-2 infection is associated with a deficiency in type I IFN response 5, 6 . In the early phase of the SARS-CoV-2 infection, a robust IFN-induced antiviral response limits viral replication and prevents severe COVID-19 illness 7, 8 . Conversely, impaired production of type I IFN is associated with higher viral titers in blood and pernicious symptoms in late-stage SARS-CoV-2-infected patients 9 .

Production of type I IFNs is controlled at several levels, including transcription and translation. Notably, multiple SARS-CoV-2 proteins inhibit Ifnb1 transcription, including NSP1, 3, 5, 6, 12, 13, 14 15, ORF3a, ORF6 and ORF7b 10, 11 . Potent translational repression of Ifnb1 mRNA is also manifested during SARS-CoV-2 infection 12 . Although SARS-CoV-2 represses general cellular mRNA translation machinery to support viral mRNA translation [12] [13] [14] , the mechanism by which it specifically represses Ifnb1 mRNA translation is not known.

Translation of most eukaryotic mRNAs is facilitated by binding of the eukaryotic initiation factor 4E (eIF4E) to the 5´ cap structure (m7GpppN, where N is any nucleotide, and m is a methyl group). eIF4E is part of the eIF4F complex, which also contains the scaffolding protein eIF4G and the RNA helicase eIF4A 15 .

Being the least abundant initiation factor, eIF4E is rate-limiting for eIF4F formation and translation initiation. The eIF4E homologous protein 4EHP (eIF4E2) also binds the cap structure but fails to initiate canonical translation because it does not bind to eIF4G. Consequently, 4EHP represses mRNAs translation upon recruitment to target mRNAs (e.g. via 4E-T protein upon recruitment by microRNAs) [16] [17] [18] [19] . GIGYF2 [Grb10-interacting GYF (glycine, tyrosine, phenylalanine) protein 2] is another protein among others that is recruited by 4EHP to the mRNA to inhibit translation or decrease stability [20] [21] [22] [23] [24] [25] .

GIGYF2 participates in both 4EHP-dependent and -independent posttranscriptional repression mechanisms 20, [22] [23] [24] . We recently reported the 4EHPmediated, miR-34a-directed translational repression of Ifnb1 mRNA 26 . This mechanism limits IFN-β production upon viral infection, likely to prohibit prolonged inflammatory responses 26 . Whether GIGYF2 is involved in the 4EHP-mediated translational repression of IFN-β is unknown.

Several large-scale proteomic studies reported the interaction of SARS-CoV-2 Non-Structural Protein 2 (NSP2) with 4EHP and GIGYF2 [27] [28] [29] . Here, we document the discovery of a mechanism by which the NSP2 protein impedes IFN-β expression through translational repression of Ifnb1 mRNA by co-opting the GIGYF2/4EHP complex, leading to evasion of cellular innate immune response and enhanced viral replication.

NSP2 specifically interacts with GIGYF2 in the GIGYF2/4EHP translation repression complex GIGYF2 and 4EHP play a crucial role in repressing mRNA translation via the miRNA-induced silencing complex (miRISC) 18, 23, 30 . We first sought to validate the interaction between NSP2 and the GIGYF2/4EHP complex in cells using the Proximity Ligation Assay (PLA). FLAG-NSP2 co-transfected with v5-GIGYF2 resulted in a strong PLA signal, which was absent in cells cotransfected with FLAG-NSP2 and v5-GIGYF1 (a paralogue of GIGYF2; Fig. 1a & b, Extended Data Fig. 1a & b) . Strikingly, we did not detect any signal upon co-transfection of FLAG-NSP2 with v5-4EHP ( Fig. 1a & b) , which indicates that NSP2 directly interacts with GIGYF2, but not with 4EHP.

Next, to investigate whether NSP2 impacts translational repression by GIGYF2, we used the λN-BoxB system to tether the λN-fused GIGYF2 to the 3´ UnTranslated Region (3´ UTR) of Renilla luciferase (R-Luc) mRNA. The reporter mRNA is protected against deadenylation by a Hammerhead ribozyme (HhR) located at its 3´ end 31, 32 . We co-transfected the reporter along with FLAG-NSP2 or FLAG-empty control plasmid. While GIGYF2-tethering alone resulted in ~50% repression [the R-Luc/F-Luc (firefly luciferase) ratio] compared to the counterpart λN vector, co-expression of NSP2 along with GIGYF2-tethering plasmid resulted in a stronger repression (~88%) ( Notably, ectopic expression of 4EHP did not affect GIGYF2-mediated repression in WT, 4EHP-KO and GIGYF2-KO cells (Fig. 2a-c) . These results support the notion that NSP2 promotes GIGYF2-induced translational repression in a 4EHP-dependent manner (Fig. 2d) . To test whether NSP2 bolsters the interaction of GIGYF2 and 4EHP, we carried out the PLA assay following co-transfection of v5-GIGYF2 and HA-4EHP into WT HEK293 cells with NSP2. As expected, the interaction between 4EHP and GIGYF2 was dramatically enhanced upon expression of NSP2 (FLAG: 19.8  1.9, FLAG-NSP2: 61  5.5 punctate per cell ( Fig. 2e & f, Extended Data Fig. 3 a-c) .

We previously reported that 4EHP suppresses Ifnb1 mRNA translation 26 . 4EHP interacts with GIGYF2 and mediates GIGYF2-induced translational repression 23, 33 . Thus, we examined the role of GIGYF2 in the regulation of IFNβ production. Toll-Like Receptor 3 (TLR3), was transiently expressed in WT, 4EHP-KO, and GIGYF2-KO HEK293 cells, which were then treated with poly(I:C), an angonist of TLR3 that stimulates IFN-β production. While 4EHP-KO cells produced ~2.5-fold more IFN-β than WT cells, as expected 26 , a significantly more robust (~5.5-fold) increase in IFN-β production was observed in GIGYF2-KO, compared with WT cells (Fig. 3a) . Furthermore, consistent with the elevated IFN-β production, poly(I:C)-induced STAT1 phosphorylation was enhanced (~3-fold) in 4EHP-KO HEK293 cells, an effect which was further augmented (~6.5-fold) in GIGYF2-KO cells (Fig. 3b ).

Next, we tested whether GIGYF2 also suppresses IFN-β production in two lung epithelial cell lines, Calu-3 and A549, which are widely used in SARS-CoV-2 studies and respond to poly(I:C) stimulation with robust IFN-β production [34] [35] [36] [37] .

Upon poly(I:C) treatment of Calu-3 and A549 cells, IFN-β expression and STAT1 phosphorylation significantly increased in the 4EHP-depleted cells (2.5~fold in Calu-3 and 1.8~fold in A549 cells) and even more in GIGYF2depleted cells compared to WT cells (6~fold in Calu-3 and 6.1~fold in A549 cells; Extended Data Fig. 4a-d) . These data demonstrate that 4EHP and GIGYF2 repress IFN-β production and that GIGYF2 is a more potent repressor than 4EHP. Importantly, Ifnb1 mRNA levels did not change in 4EHP-or GIGYF2-depleted cells compared to their control counterparts (Extended Data Next, we investigated whether formation of the GIGYF2/4EHP complex is required for repression of IFN-β production. Rescuing expression of 4EHP, which is destabilized in GIGYF2-depleted cells 20 , failed to restore repression of IFN-β production in GIGYF2-KO HEK293 cells (Fig. 3c, Extended Data Fig. 5a ).

These data indicate that repression of IFN-β production by 4EHP requires the presence of GIGYF2. To determine whether direct interaction of 4EHP with GIGYF2 is required for repression of IFN-β production, we overexpressed 4EHP and WT GIGYF2 or a mutant version of GIGYF2 that does not bind to 4EHP (GIGYF2M) 20 Fig. 5d ). These data support the conclusion that GIGYF2-depletion protects A549 cells from VSVΔ51-GFP infection, owing to robust IFN-β production and activation of IFN-induced antiviral pathways.

We next asked whether GIGYF2 also directly targets virus-induced activation of signaling pathways upstream of IFN-β. We first examined the impact of GIGYF2 or 4EHP depletion on virus RNA sensor-initiated signaling. We co- The reporter expression was repressed ~2-fold upon ectopic expression of NSP2, but not NSP1 or E protein (Fig. 4a, Extended Data Fig. 6a ). To examine whether NSP2-mediated repression of R-Luc-Ifnb1 3´ UTR reporter requires the GIGYF2/4EHP complex, reporter activity was measured in WT, 4EHP-KO, and GIGYF2-KO cells expressing either GFP or NSP2 (Extended Data Fig. 6b ).

R-Luc-Ifnb1 3´ UTR was consistently repressed by 2-fold in the NSP2transfected WT cells compared to the GFP-transfected WT cells (Fig. 4b) ,

without affecting R-Luc mRNA levels (Extended Data Fig. 6c ). However, reporter R-Luc-Ifnb1 3´ UTR silencing was relieved in 4EHP-KO and GIGYF2-KO cells, regardless of the expression of NSP2 (Fig. 4b) . Thus, the NSP2induced Ifnb1 3´ UTR-dependent repression requires the presence of 4EHP and GIGYF2. Notably, transient expression of NSP2 in WT HEK293 cells elicited a ~40% and ~48% increase in endogenous GIGYF2 and 4EHP protein levels, respectively (Extended Data Fig. 6b &d-e), without affecting the GIGYF2 and 4EHP mRNA levels (Extended Data Fig. 6f & g) . This is likely due to the NSP2-induced enhanced GIGYF2 and 4EHP interaction (Fig. 2) , which engenders mutual stabilization of both proteins 20 .

Next, we wished to confirm the above results in the lung epithelial cell line A549.

We used lentiviral vectors to stably express NSP2 or control empty vector (EV) in WT and GIGYF2-KO A549 cells. Compared to the empty vector, ectopic NSP2 expression reduced the poly(I:C)-induced IFN-β production (~4-fold; Fig.   4c ) and STAT1 phosphorylation (Fig. 4d) in WT cells, without a significant impact on Ifnb1 mRNA levels (Extended Data Fig. 7a) . In stark contrast, NSP2 failed to repress IFN-β production or STAT1 phosphorylation in GIGYF2-KO cells (Fig. 4c & d) . Notably, similar to HEK293 cells (Extended Data Fig. 6b ), stable expression of NSP2 in A549 cells resulted in a 2-fold and 0.8-fold increase in GIGYF2 and 4EHP protein levels, respectively, without changes in GIGYF2 and 4EHP mRNA levels (Extended Data Fig. 7b-e) . However, stabilization of 4EHP by NSP2 was not observed in NSP2-expressing GIGYF2-KO cells, because NSP2 directly interacts with GIGYF2, but not 4EHP.

Taken together, our data offer a mechanistic model in which NSP2 directly interacts with host GIGYF2 protein and enhances the interaction of GIGYF2 with 4EHP, resulting in stabilization of both GIGYF2 and 4EHP proteins. We show that NSP2 co-opts the GIGYF2/4EHP translational repression complex to suppress IFN-β production. The NSP2-induced enhancement of translational repression of Ifnb1 mRNA and IFN-β production compromises antiviral immunity and is predicted to facilitate SARS-CoV-2 replication and exacerbate viral pathogenesis (Model; Fig. 4e ).

Next, we sought to understand the structural basis for the interaction between NSP2 and GIGYF2 using simulation programs, as the 3D structure of GIGYF2 is not resolved. Therefore, we queried human GIGYF2 (accession number: Q6Y7W6) against the Pfam database 39 to predict its domains and folded regions. GIGYF2 is predicted to possess the known GYF motif (correctly designated between residues 557-601) in addition to a domain of unknown function spanning residues 744-940 (Fig. 5a) . We performed secondary structure prediction on human GIGYF2 by the Garnier-Osgurthorpe-Robson IV (GOR4) method 40 . Consistent with the Pfam result, the region in GIGYF2 roughly spanning residues 750-950 is predicted with high confidence to fold into alpha helices (Extended Data Fig. 8a ). To investigate the helical organization of GIGYF2 (744-940), we mapped this region back to a full-length threedimensional model of human GIGYF2 as predicted by AlphaFold 2 16, 41 . GIGYF2

(744-940) corresponds to a region in the model that is confidently predicted (Extended Data Fig. 8b & c) to fold into one singular, long alpha helix (Fig. 5a) .

Thus, our structural analysis of GIGYF2 reveals that this previously uncharacterized GIGYF2 region (744-940) corresponds to a singular alpha helix [hereafter referred to as the GIGYF2 long helix region (GIGYF2-LHR)].

We next sought to model the interaction between GIGYF2 and NSP2. A cryo-EM structure of SARS-CoV-2 NSP2 that modelled 68% of the total protein sequence 42 was obtained from the Protein Data Bank (PDB code: 7MSX).

There are natural variants of SARS-CoV-2 that possess glycine to valine point mutations at residues 262 and 265 in NSP2 43 . A recent study 42 used an affinity purification mass-spectrometry (AP-MS) assay to investigate the changes in NSP2's virus-host protein-protein interactome caused by naturally occurring mutations. Strikingly, an NSP2 G262V/G265V double mutant expressed in HEK293T cells failed to interact with the GIGYF2 and 4EHP 42 . A model for the interaction between GIGYF2 and NSP2 should therefore include and track the positions of G262/G265. To determine the 3D location of G262/G265 within folded NSP2, the intra-protein folding organization of NSP2 was predicted by analyzing its amino acid sequence with ColabFold 44 . NSP2 is predicted to contain five discrete folding units, four of which could be allocated to its cryo-EM structure ( Fig. 5b, Extended Fig. 9a-d) . G262/G265 occurred in a short alpha helix contained in a predicted folding unit spanning residues 251-375 (NSP2-R3) (Extended Data Fig. 9e) . To model the interaction between GIGYF2 and NSP2 we performed protein-protein docking simulations between GIGYF2-LHR and either NSP2-R3 or the cryo-EM structure of NSP2 using HADDOCK 2.4 45 .

Simulations between GIGYF2-LHR and NSP2-R3 yielded 8 docking models grouped into 2 clusters; cluster 2 had the lower and better HADDOCK score (Extended Data Fig. 10a ). The best model of cluster 2 docked NSP2-R3 at the center of GIGYF2-LHR in a manner that positioned the G262/G265 containing helix proximal and parallel to GIGYF2-LHR (Extended Data Fig. 10c ).

Simulations between GIGYF2-LHR and the cryo-EM structure of NSP2 yielded 25 docking models grouped into 10 clusters, with cluster 6 performing with the lowest HADDOCK score (Extended Data Fig. 10b ). The best model in this cluster also docked NSP2 at the center of GIGYF2-LHR with the helix containing G262/G265 directly adjacent to GIGYF2-LHR (Fig. 5c, Extended   Data Fig. 10d) . Overall, our docking simulations generated models for the interaction between GIGYF2 and NSP2 that were consistent with our structural analyses of these proteins and with the AP-MS data in the literature 42 .

While a robust type I IFN-mediated antiviral innate immune response is indispensable for combating infections, an exacerbated response can result in pathological inflammation and tissue damage [46] [47] [48] [49] . mRNA translational control mechanisms play a crucial role in maintaining the appropriate magnitude and duration of the immune response 49 . Our data show that the GIGYF2/4EHP complex inhibits translation of Ifnb1 mRNA. We demonstrate that SARS-CoV-2 co-opt this mechanism through NSP2 protein, which is highly conserved among coronaviruses 42 to impede upon the antiviral innate immune response.

Thus, this mechanism is presumably utilized by other coronaviruses. Indeed, a previous study detected the interaction of SARS-CoV-1 encoded NSP2 with GIGYF2 and 4EHP 50 , indicating a common mechanism of impeding the host innate immune response by coronaviruses. We further revealed that another RNA virus (VSV) also employs the GIGYF2/4EHP complex to repress IFN-β production (Fig. 3) 26 . Thus, it appears that various RNA viruses use distinct approaches that converge on GIGYF2/4EHP translational repression complex to block the activation of the antiviral innate immune response.

Other SARS-CoV-2 proteins including NSP1 and NSP14 also dysregulate the host mRNA translation machinery 13, 16, 28, 50, 51 . NSP1 blocks the ribosomal entry site for host mRNAs but allows SARS-CoV-2 mRNA translation 52, 53 . While viral RNA is protected, host mRNA is subjected to degradation. Thus, NSP1 nonspecifically inhibits translation of host mRNAs including Ifnb1 53 and results in depletion of labile antiviral factors such as Tyk2 and STAT2 54 . NSP14 also inhibits global mRNA translation, which likewise involves the shutdown of ISGs expression 51 . In contrast, we showed that NSP2 associates with the GIGYF2/4EHP complex to repress translation of Ifnb1 mRNA, but it is highly likely that this mechanism also affects the expression of other important cytokines that promote antiviral response.

The N-terminal region of GIGYF2 encodes several important protein binding motifs, including the 4EHP-binding motif 20 , DDX6-binding motif, and the GYF domain which interacts with the Pro-Pro-Gly-hydrophobic motif (PPGL) 20,55 . We 

CRISPR-Cas9-mediated genome editing of Flp-In T-REx HEK293 cells was performed as previously described 58 

GFP-expressing VSVΔ51-GFP was previously described 59 . Virus titer was determined using a standard plaque assay protocol 60 

Cells were harvested and RNA was isolated using mammalian total RNA isolation kit (Sigma, RTN70-1KT). Following the Superscript III reverse transcriptase protocol (Invitrogen), equal amounts of total RNA (1 μg) were used for reverse transcription with 100 ng random primers. mRNA abundance was estimated via real-time PCR system (Mastercycler Realplex, Eppendorf) using SYBR Green master mix (Bio-rad). All primers are listed in Extended Data For the tethering assay, we used the λN-BoxB tethering approach 32 . Briefly, a R-Luc reporter containing five BoxB hairpins in its 3′ UTR was used. The 3′ end of the reporter contains a self-cleaving hammerhead ribozyme (HhR) to generate an internalized poly(a) stretch to prevent deadenylation and subsequent degradation 31 . The reporter was co-transfected along with the construct encoding a fusion of the protein of interest ORF, like GIGYF2, to a λN peptide, which allows GIGYF2 to bind to reporter BoxB elements. HEK293 cells were co-transfected with the constructs expressing either λN-V5 control or λN- Cells were washed by Wash Buffer A before incubation with PLA probe for 1 h at 37 ℃, followed by ligation for 30 min at 37℃. PLA signals were amplified using Amplification Buffer for 100 min at 37℃, followed by washing with Wash Buffer B and mounting onto the slide glass before Airyscan microscopic imaging (Zeiss).

Statistical tests were performed using Prism 6 (GraphPad). Error bars represent standard deviation (SD) from the mean. Number of independent replicates (3) and the statistical analysis used for each assay is described in the relevant figure legends. P values <0.05 were considered significant. 

Type I interferons in infectious disease

Inhibition of SARS-CoV-2 by type I and type III interferons

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV

Antiviral activities of type I interferons to SARS-CoV-2 infection

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome

Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-beta

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

SARS-CoV-2 suppresses IFNbeta production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon

Activation and evasion of type I interferon responses by SARS-CoV-2

Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection

SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis

Dysregulation of Cell Signaling by SARS-CoV-2

Regulation of translation initiation in eukaryotes: mechanisms and biological targets

eIF4E-homologous protein (4EHP): a multifarious cap-binding protein

Translational control of ERK signaling through miRNA/4EHP-directed silencing

Cap-binding protein 4EHP effects translation silencing by microRNAs

microRNA-mediated translation repression through GYF-1 and IFE-4 in C. elegans development

A novel 4EHP-GIGYF2 translational repressor complex is essential for mammalian development

Ribosome collisions trigger cis-acting feedback inhibition of translation initiation

GIGYF2 and 4EHP Inhibit Translation Initiation of Defective Messenger RNAs to Assist Ribosome-Associated Quality Control

4EHP-independent repression of endogenous mRNAs by the RNA-binding protein GIGYF2

Recruitment of the 4EHP-GYF2 cap-binding complex to tetraproline motifs of tristetraprolin promotes repression and degradation of mRNAs with AU-rich elements

microRNA-mediated translation repression through GYF-1 and IFE-4 in C. elegans development

microRNA-induced translational control of antiviral immunity by the cap-binding protein 4EHP

Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes

Post-transcriptional gene silencing activity of human GIGYF2

MicroRNAs mediate gene silencing via multiple different pathways in drosophila

Using the lambdaN peptide to tether proteins to RNAs

GIGYF1/2 proteins use auxiliary sequences to selectively bind to 4EHP and repress target mRNA expression

CoV-2 cellular tropism

SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells

Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection

Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells

Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas

Pfam: The protein families database in 2021

GOR method for predicting protein secondary structure from amino acid sequence

Highly accurate protein structure prediction with AlphaFold

CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes. bioRxiv

Snapshot of the evolution and mutation patterns of SARS-CoV-2. bioRxiv

ColabFold -Making protein folding accessible to all. bioRxiv

The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes

Post-transcriptional control of cytokine production

Type I interferon in systemic lupus erythematosus and other autoimmune diseases

Post-transcriptional regulation of immune responses by RNA binding proteins

Posttranscriptional regulation of gene expression in innate immunity

Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling

Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation

Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2

SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors

Molecular basis for GIGYF-Me31B complex assembly in 4EHP-mediated translational repression

Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors

The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways

Genome engineering using the CRISPR-Cas9 system

Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

along with R-Luc-5BoxB-A114-N40-HhR and F-Luc (as control), followed by dual-luciferase measurement assay. Data are presented as mean ± SD (n=3). ***p<0.001, one-way ANOVA with Bonferroni's post hoc test. The schematic shows a graphic model of λN-v5-GIGYF2 tethering system. (d) Analysis of λN-v5-GIGYF2 tethering-induced silencing in GIGYF2-KO cells that overexpress FLAG-NSP2. Data are presented as mean ± SD (n=3). ns= non-significant, one-way ANOVA with Bonferroni's post hoc test

a) WT cells were cotransfected with vectors expressing either λN-v5-GIGYF2 or λN-v5 control, along with R-Luc-5BoxB-A114-N40-HhR and F-Luc (as control), in combination with FLAG-4EHP or FLAG-Empty plasmids. Dual-luciferase assay was performed 24 h post-transection. Data are presented as mean ± SD (n=3). *p<0.05, one-way ANOVA with Bonferroni's post hoc test. (b-c) GIGYF2-tethering assay carried out in 4EHP-KO cells in (b) and GIGYF2-KO cells in (c

The number of PLA signals from at least 20 cells was counted in each sample. n=5 independent experiments. Data are presented as mean ± SD (n=5). ****P< 0.0001, one-way ANOVA with Bonferroni's enabling viral replication. (a) ELISA measurement of IFN-β production in WT, 4EHP-KO, and GIGYF2-KO HEK293 cells transiently expressing TLR3 following 6 h of treatment with poly(I:C). Data are presented as mean ± SD (n=3). ****P< 0.0001, one-way ANOVA with Bonferroni's post hoc test. (b) Western blot analysis of cell lysates from (a). (c) WT and GIGYF2-KO HEK293 cells were transfected with the plasmids expressing v5-Empty or v5-4EHP. ELISA measurement of IFN

) v5-Empty or v5-4EHP expression plasmids were co-transfected with empty vector (EV) or plasmids expressing WT GIGYF2 or 4EHP-binding mutant GIGYF2 (Y41A, Y43A, M48A, L49A; GIGYF2M). IFN-β ELISA assay was performed following 6h of poly(I:C) stimulation. Data are presented as mean ± SD (n=3). ***P< 0.001, one-way ANOVA with Bonferroni's post hoc test

Luc-Ifnb1 3´ UTR reporter or the psiCHECK2 reporter (as control). R-Luc and F-Luc activities were measured 24 h after transfection. The R-Luc/F-Luc ratio

Luc-Ifnb1 3´ UTR reporter expressing cells was normalized to the psiCHECK2-expressing cells. Data are presented as mean ± SD (n=3). ns= non-significant, **P< 0.01, ***P< 0.001, two-way ANOVA with Bonferroni's post hoc test. (f-i) WT or

cells were subjected to: (f) visualization of VSVΔ51-GFP infection by fluorescence microscopy, (g) Quantification of the GFP positive cell number in (f) by

ELISA measurement of IFN-β production in the supernatant. (i) At the indicated time points post virus infection, ISG56 mRNA levels were measured by RT-qPCR. GAPDH mRNA was used for normalization

****P< 0.0001, one-way ANOVA with Bonferroni's post hoc test. See also Extended Data Fig. 4 and Fig

(a) 24 h post-transfection with GFP, NSP2, NSP1, or E protein, HEK293 cells were transfected with psiCHECK2-R-Luc-Ifnb1 3´ UTR reporter or the psiCHECK2 reporter (control). R-Luc and F-Luc activities were measured 24 h after the 2 nd transfection. The R-Luc/F-Luc ratio of psiCHECK2-R-Luc-Ifnb1 3´ UTR cells was normalized to the value for the psiCHECK2 cells as a percentage. Data are presented as mean ± SD (n=3). ns= non-significant, *p< 0.05, two-way ANOVA with Bonferroni's post hoc test. (b) WT, 4EHP-KO, and GIGYF2-KO HEK293 cells were transfected with GFP or NSP2 expression plasmid

ELISA measurement of IFN-β and (d) western blot analysis of poly(I:C) treated WT and GIGYF2-KO A549 cells stably expressing either empty vector (EV) or NSP2 using lentiviral vector at 8 h post transfection. Data are presented as mean ± SD (n=3). ns= non-significant, ***p< 0.001, two-way ANOVA with Bonferroni's post hoc test was used. (e) Graphic illustration of recruitment of the GIGYF2/4EHP repressor complex by NSP2 to silence IFN-β production in response to SARS-CoV-2 infection. GIGYF2/4EHP complex enables the miRISCinduced repression of the cap-dependent mRNA translation. Binding of NSP2 to GIGYF2 enhances the interaction of GIGYF2 with 4EHP, resulting in co-stabilisation of GIGYF2 and 4EHP and augmented translational repression of Ifnb1 mRNA

The predicted three-dimensional structure of GIGYF2 was obtained from the AlphaFold Protein Structure Database and annotated in PyMOL: cyan -long helix region, orange -GYF domain, grey -rest of GIGYF2. The schematic of predicted domains and folding regions along the primary structure of GIGYF2 was generated by querying human GIGYF2 (accession number: Q6Y7W6) against the Pfam database. Grey -regions predicted to be disordered, blue -regions predicted to have low complexity, green -regions predicted to fold into known domains or secondary structures. (b) Cryo-EM structure of SARS-CoV-2 NSP2. The cryo-EM structure of NSP2 (4-104, 119-475, 491-505) was obtained from the Protein Data Bank (PDB code: 7MSX). Discrete folding regions within NSP2 were annotated in PyMOL: red -NSP2-R1, green -NSP2-R2, magenta -NSP2-R3, yellow -NSP2-R4. (c) Model of the interaction between GIGYF2-LHR and NSP2 by HADDOCK 2.4. The predicted model was annotated in PyMOL as follows: cyan -GIGYF2-LHR ribbon model superimposed over a GIGYF2-LHR 60% transparent surface model, magenta -NSP2 cryo-EM ribbon model superimposed over an NSP2 cryo-EM 60%

We thank Samer Girgis and Trista Lou for technical assistance. This work was supported by grants from the Canadian Institutes of Health Research (CIHR; FDN-148423)